AI Analysis AI Analysis of ANAB AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add ANAB to Watchlist?
Some Reasons Why To Add ANAB:
  • +277.5% price growth over the last year
  • High gross margin of 116.4%
  • Strong return on equity of 442.9%
PDF

AnaptysBio Inc stock downgraded to Sell Candidate
(Updated on Jun 24, 2026)

Sell candidate since Jun 24, 2026

The AnaptysBio Inc stock price fell by -1.60% on the last day (Wednesday, 24th Jun 2026) from $59.43 to $58.48. During the last trading day the stock fluctuated 3.89% from a day low at $58.25 to a day high of $60.51. The price has risen in 6 of the last 10 days and is up by 13.27% over the past 2 weeks. Volume has increased on the last day by 81 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 467 thousand shares were bought and sold for approximately $27.33 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 25.09% during the next 3 months and, with a 90% probability hold a price between $64.72 and $98.43 at the end of this 3-month period.

ANAB Signals & Forecast

There are mixed signals in the stock today. The AnaptysBio Inc stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $58.68. On a fall, the stock will find some support from the short-term average at $58.47. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Monday, May 04, 2026, and so far it has fallen -16.19%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for AnaptysBio Inc stock

On the downside, the stock finds support just below today's level from accumulated volume at $50.95 and $45.82. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, AnaptysBio Inc finds support just below today's level at $50.95. If this is broken, then the next support from accumulated volume will be at $45.82 and $45.01.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $2.27 between high and low, or 3.89%. For the last week, the stock has had daily average volatility of 5.14%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ANAB) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect AnaptysBio Inc to open at $59.08, and during the day (based on 14 day Average True Range), to move between $56.93 and $60.03, which gives a possible trading interval of +/-$3.11 (+/-5.46%) up or down from last closing price. If AnaptysBio Inc takes out the full calculated possible swing range there will be an estimated 5.46% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $58.88 (0.68%) than the support at $50.95 (12.88%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is AnaptysBio Inc stock A Buy?

AnaptysBio Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

Current score: -2.494 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 25, 2026 - $59.08 ( 1.02%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

ANAB Performance

Trading levels for ANAB

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 61.34 4.90%
R2 60.48 3.42%
R1 59.94 2.50%
Price 58.48
S1 58.21 -0.456%
S2 57.68 -1.37%
S3 56.81 -2.85%

Accumulated Volume Support & Resistance Levels

Level Price
R3 66.96 14.50%
R2 66.59 13.87%
R1 58.88 0.684%
Price 58.48
S1 50.95 -12.88%
S2 45.82 -21.65%
S3 45.01 -23.04%

FAQ

What is the symbol for AnaptysBio Inc Stock and on which exchange is it traded?
The symbol for AnaptysBio Inc is ANAB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell AnaptysBio Inc Stock?
AnaptysBio Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

How to buy AnaptysBio Inc Stock?
AnaptysBio Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy AnaptysBio Inc Stock.

What's the current price of AnaptysBio Inc Stock?
As of the end of day on the Jun 24, 2026, the price of an AnaptysBio Inc (ANAB) share was $58.48.

What is the 52-week high and low for AnaptysBio Inc Stock?
The 52-week high for AnaptysBio Inc Stock is $72.27 and the 52-week low is $11.40.

What is the market capitalization of AnaptysBio Inc Stock?
As of the Jun 24, 2026, the market capitalization of AnaptysBio Inc is 2.522B.

When is the next earnings date for AnaptysBio Inc?
The upcoming earnings date for AnaptysBio Inc is Aug 05, 2026.
Click to get the best stock tips daily for free!
ABOUT ANAPTYSBIO INC
AnaptysBio
AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications. Its products include Imsidolimab, an antibody that inhibits the interleukin-36 receptor (IL-36R) for the treatment of various dermatological inflammatory diseases; Rosnilimab, an anti-PD-1 agonist antibody program designed to augment PD-1 signaling through rosnilimab treatment to suppress...
GOLDEN STAR
Ticker Change Signal Date
NESR
$25.06
0.439% Jun 22
IDYA
$28.98
25.19% Jun 12
PHM
$118.49
14.53% Jun 10
DHI
$146.71
13.50% Jun 10
EAT
$140.46
20.94% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE